InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,961.82
(
-0.98%
)
US TECH 100
16,576.80
(
-2.12%
)
Dow Jones
37,967.31
(
0.51%
)
Brent Oil
86.68
(
0.31%
)
Bitcoin
64,184.04
(
1.06%
)
Post# of 316359
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

cintrix

Send PM Follow Ignore
Followers 363
Posts 113738
Boards Moderated 5
Alias Born 12/28/2000

cintrix

Member Level

Re: None

Thursday, 06/02/2022 3:41:47 PM

Thursday, June 02, 2022 3:41:47 PM

Post# of 316359
CNTA down 26% discontinuing development of lixivaptan - The company said it believes that with its decision to discontinue development of lixivaptan, it is well positioned with the capital and resources to execute its other programs. It said it expects a significant reduction in annual cash burn, and sees its cash runway now extending into 2026.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up